Trade Now

Capital at risk Advertisement
Share Name Share Symbol Market Type Share ISIN Share Description
Eco Animal Health Group Plc LSE:EAH London Ordinary Share GB0032036807 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 100.00 98.00 102.00 100.00 100.00 100.00 45,161 07:31:24
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 105.6 20.3 12.1 8.3 68

Eco Animal Health Share Discussion Threads

Showing 1376 to 1400 of 1400 messages
Chat Pages: 56  55  54  53  52  51  50  49  48  47  46  45  Older
DateSubjectAuthorDiscuss
11/8/2022
07:43
free stock charts from uk.advfn.com
buywell3
10/8/2022
14:15
As you say, results are now keenly awaited . Ahead of that, short note on the TU and financial news out from Equity Dev. Also notes that valuation ratings starting to look low in the sector after steady share price falls. Free access here: https://www.equitydevelopment.co.uk/research/trading-update-triggers-share-price-fall
edmonda
09/8/2022
08:32
Rivaldo you are smarter than me by avoiding this share. My book loss is comfortably the largest of my holdings. Will be interesting to see what Singer says when the results come out. Note that a long standing NED resigns with immediate effect.
cerrito
08/8/2022
16:20
Consensus Mean consensus BUY Number of Analysts 3 Last Close Price 127,50 GBX Average target price 271,33 GBX Spread / Average Target 113% High Price Target 350,00 GBX Spread / Highest target 175% Low Price Target 200,00 GBX Spread / Lowest Target 56,9% marketscreener.com - S&P Global Market Intelligence
la forge
08/8/2022
16:08
Good point fastbuck - hands up who thinks the analysts will forecast the improved trading conditions before they actually happen?!
tradertrev
08/8/2022
15:05
I think you need to play the Chinese demand, once it's in the broker forecasts the share price will be up significantly, buy whilst the broker estimates are on the floor and hog prices are climbing. Remember that they still have strong demand from ROW and R and D efforts are moving in right direction creating new products. Whilst some heavy weight investors still on the share register, I understand, whilst trading at below net tangible assets
fastbuck
08/8/2022
14:00
Not a holder here, but a (very!) long-term observer with EAH never having moved from watchlist to actual portfolio. Had to comment on an earlier post that today's update was in line. Singer have issued an update note stating that the actual £6.5m EBITDA compares to their £7.1m forecast, so is quite a large miss. They'll update all forecasts after the results, but the historic number will now evidently be lower than the previously forecast 2p EPS. Their "initial stab" for the current year suggests in light of the "soft start" to the year in China that "a flat year is in prospect", suggesting that EPS to March'23 will also be recalculated down to say 1.8p EPS or so.
rivaldo
08/8/2022
11:16
Reminder: on 12th May the CEO bought 33K shares at 117p. He must have had a realistic assessment of the the situation and future prospects, so it’s reasonable to judge any price lower than this to be very good value.
aimingupward2
08/8/2022
10:50
Think that's a bit harsh. His first 18 months was spent chasing down earlier accounting errors and re-jigging the previous 10 years' accounts. There has also been massive restriction on international travel to enable "whites of the eyes" interrogation of local accounting staff. An R&D change in accounting can happen at any time to any company. Then there is the small matter of the substantial investment Mr Wilks has made in the shares - something woefully missing with many other AIM companies. He still has my confidence and I have made a small top up investment this morning.
tradertrev
08/8/2022
10:22
I repeat a comment that I have made before namely that s company with three joint brokers( and why they need 3 brokers would be a good question for their next IMC type event) produces a RNS which you need to read 2/3 times to get a sense of what is going on. In terms of the tax, my first reaction was what a load of accident prone plonkers. I can understand why they did not want to explicitly name the country and if it is one with many confusing tax regulations like Brazil I would be prepared to cut them some slack. That and the R&D issue suggests that the Finance area lacks grip, despite the quote new unquote FD being in post since August 2019. My reading is that H2 sales 21/22 were £44m down from £64m for H2 2020/21. Nice to see strong non China sales in Q1 of this FY and and thus a more balanced geographic spread of sales. My reading of the share price fall is that it is not driven by trading per se but rather lack of credibility in the Finance function.
cerrito
08/8/2022
09:29
I actually take it that the 6.5m EBITDA (which was in line with the 6-7m forecast) was after the 1m CY charge for import tax which was coded to Cost of Sales, and R&D which was coded to overheads. Actually I think they were indicating that the results were a slight beat when factoring in these numbers without being too clear
fastbuck
08/8/2022
08:30
Yes , encouraging news is re current FY after the charges re past year. FY results due out c. 18 August, and co says that y/e to 31 March should see revs £82m< and EBITDA c. £6.5m. Its making £2.5m sales tax provision, and £0.3m adj re capitalised costs. Q1 new FY saw strong gross margins in China + improvement in pork pricing.
edmonda
08/8/2022
08:15
In line with broker note. Not sure what the fuss is, more importantly we are seeing recovery in China which is a positive, and strength elsewhere.
fastbuck
08/8/2022
07:48
Not sure this was the update we wanted.
tradertrev
22/7/2022
17:35
Https://www.marketscreener.com/quote/stock/ECO-ANIMAL-HEALTH-GROUP-P-4003649/
waldron
22/7/2022
16:41
Nevertheless/whatever, there has been steady buying all day today and the price has moved up with it.
aimingupward2
13/7/2022
23:25
The sad reality is that they were very sensible to do the bank financing announced the other day and the further sad reality is that any dividend we are likely to get in the next few years will be nominal
cerrito
13/7/2022
20:29
By my calculations the last Balance Sheet had £60m of net current assets less all liabilities, it is profitable despite expensing £8m of R&D this year and is only valued at £76m. All other IP, vaccines in for free.Chinese Pork prices have risen significantly in last few months which will help FY23 if they are maintained.You have George Soros on the share registerWhat is not to like, I have just taken a new position after being a past shareholder a few years back.
fastbuck
06/7/2022
11:13
Collaboration to develop poultry red mite vaccine - new research note by Equity Development (Full link here: https://www.equitydevelopment.co.uk/research/collaboration-to-develop-poultry-red-mite-vaccine) ECO Animal Health has established a research collaboration with Moredun Research Institute aimed at developing a potential first-in-class vaccine against poultry red mite, a blood-feeding parasite with welfare and production implications for egg-laying hens. The move represents ECO’s second new academic R&D collaboration this year and follows an agreement signed with Imperial College last month to develop vaccines against porcine infectious diseases. Moredun is an independent, although largely government funded, scientific research institution based in Scotland focussed on animal/veterinary health. The three-year project appears to build on the work of Moredun’s researchers, who have notably been able to establish a laboratory colony of poultry red mites and have tested a prototype vaccine based on extracts from the mite. The project intends to use a reverse vaccinology approach to identify epitopes by analysing bio-informatic data from an infection model across the developmental stages of the mite. The aim will be to generate a synthesisable vaccine that can be tested in Moredun’s poultry red mite challenge model. Poultry red mite (Dermanyssus gallinae) is one of the most important causes of production losses in laying hens, including by acting as vectors for pathogenic bacteria (including salmonella, E. coli and mycoplasmas) and viruses. The mite can feed on up to 5% of a bird’s blood overnight, causing anaemia and stress that can induce feather pecking, cannibalism and increased feed consumption. As there are no effective non-chemical solutions, insecticides are used to kill the mites but this has its own risks including the potential for chemical residues in the eggs/meat and development of resistance. Over 90% of farms in Western Europe are infested with poultry red mite. ECO’s shares have fallen to their lowest point since October 2008, primarily on concerns around weakness in the Chinese pork market, as the economics of pork production are a key driver of demand for Aivlosin. Chinese pork prices have been highly volatile over the past three years, after an African Swine Fever outbreak in 2019 and its knock-on effects, compounded by the pandemic and the government’s zero-Covid policy. Chinese pork prices fell throughout 2021 (from an unusual high) and into 2022. However, since May they have recovered to a level where Aivlosin demand should stabilise. ECO is due to report its financial results shortly, with consensus suggesting sales of c. £81.5m and adjusted EBITDA of £6-7m. Both will be lower than exceptional levels seen in 2021. ECO’s enterprise value is currently £54m (based on forecast cash of c £18m), suggesting an EV/sales ratio of <0.7 and EV/EBITDA of ~8-9, both of which are well below norms in the animal health sector. ECO resumed payment of a dividend in 2021, at 1p/share, that if repeated, would offer a yield of 0.9%.
edmonda
24/6/2022
21:28
Article in the FT the other day on the role of increase in pork prices in the general inflation situation in China. Commented that profits of hog producersike Muyuan being squeezed given increase in price of animal feed . It also said the share price of Muyuan suffering but actually only down 1.5pc YTD. Anyway suggests to me that there continue to be headwinds for EAH despite increase in pig prices.
cerrito
17/6/2022
15:01
at least pig prices have edged up in recent weeks from below 13 to just under 16. On the other hand the ANP AGM statement the other day not inspire confidencde
cerrito
17/6/2022
09:28
Was watching these a few weeks back when Director CFO was buying back at £1.60, good update cheers.
brut winky
17/6/2022
09:20
Encouraging expansion of vaccine R&D pipeline (new research note from Equity Development) ECO Animal Health has undertaken what represents a potentially important expansion of its R&D pipeline via a collaboration to develop veterinary vaccines against three porcine infectious disease targets using a novel self-amplifying RNA (saRNA) technology developed by Professor Robin Shattock of Imperial College London. The collaboration will assess saRNA-based veterinary vaccines against two viral and one bacterial infection in ECO’s validated swine disease models with a view to selecting candidates for development and commercialisation under license from Imperial College. The company is due to report its financial results for the year to March 2022 next month, with consensus suggesting sales of c. £81.5m and adjusted EBITDA of £6-7m. Both will be lower than exceptional levels seen in 2021. Current ECO’s enterprise value is £64m (based on forecast cash of c £18m) suggesting an EV/sales ratio of 0.8 and EV/EBITDA of ~9-10, both of which are well below norms in the animal health sector (peer group EV/sales 2.5-3.0x). ECO resumed payment of a dividend in 2021, at 1p/share, that if repeated, would offer a yield of 0.8%. Link to note: https://www.equitydevelopment.co.uk/research/encouraging-expansion-of-vaccine-rd-pipeline
edmonda
15/6/2022
08:37
The share price is 120p The cable is US1.20 This must be a bargain for a dollar based investor
cerrito
15/6/2022
08:17
Pleased to read this news today and let us hope we will be able to harvest the benefits is 2026.
cerrito
Chat Pages: 56  55  54  53  52  51  50  49  48  47  46  45  Older
ADVFN Advertorial
Your Recent History
LSE
EAH
Eco Animal..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220815 01:10:36